Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Mikaela Naylon Give Kids a Chance Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 3014 Ensuring Timely Access to Generics Act of 2025 S. 1414 Expedited Access to Biosimilars Act S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act
Mikaela Naylon Give Kids a Chance Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
THE FINTECH ACCORD via WHITMER & WORRALL, LLC
2026 · third_quarter · Q3
Issues related to S. 394, the GENIUS Act of 2025. Issues related to the Congressional FinTech and Payments Caucus. Issues related to artificial intelligence and payments. Issues related to H.R. 3633, the Digital Asset Market Clarity Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PAYSAFE PAYMENT PROCESSING SOLUTIONS, LLC via WHITMER & WORRALL, LLC
2026 · third_quarter · Q3
Source: Senate LDA
| CHARLOTTE MECKLENBURG HOUSING PARTNERSHIP | 34 | 2006–2014 |
| HERITAGE CONSTRUCTION AND MATERIALS | 30 | 2016–2023 |
| TRIDENTCARE | 29 | 2020–2026 |
| INDIANA REGIONAL MEDICAL CENTER | 28 | 2008–2026 |
| SARNOVA, LLC | 28 | 2020–2026 |
| VIRGIN AMERICA | 28 | 2006–2013 |
| PANASONIC CORPORATION OF NORTH AMERICA | 27 | 2020–2026 |
| HONEYWELL INTERNATIONAL | 26 | 2009–2015 |
| NEURO KINETICS | 26 | 2009–2015 |
| PPG INDUSTRIES INC | 24 | 2013–2019 |
| EVOQUA WATER TECHNOLOGIES | 22 | 2018–2023 |
| PLEXTRONICS INC | 21 | 2005–2011 |
| DECISION LENS | 20 | 2011–2019 |
| ARCHIDATA INC | 19 | 2010–2014 |
| SMR AUTOMOTIVE SYSTEMS USA INC. | 18 | 2021–2026 |
| UNIVERSITY OF CENTRAL FLORIDA | 18 | 2020–2024 |
| UTC OVERSEAS, INC. | 18 | 2013–2017 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | 17 | 2011–2014 |
| COALITION FOR INDEPENDENT SENIORS (CIS) | 15 | 2010–2013 |
| EUROFINS TRANSPLANT GENOMICS INC. | 15 | 2023–2026 |
| GHOSTWORKS MARINE | 15 | 2023–2026 |
| THERMAXX | 15 | 2016–2019 |
| ABERTIS INFRAESTRUCTURES | 14 | 2005–2009 |
| ASSOCIATION OF AMERICAN RAILROADS | 14 | 2014–2017 |
| BARBOUR GRIFFITH & ROGERS, LLC D/B/A BGR GOVERNMENT AFFAIRS | 14 | 2010–2013 |
| UNIVERSITY OF NORTH FLORIDA | 14 | 2022–2025 |
| MAKANA MASK INC. | 13 | 2020–2023 |
| REDZONE ROBOTICS, INC. | 13 | 2008–2012 |
| UTILITIES TECHNOLOGY COUNCIL | 13 | 2016–2019 |
| X-MAT | 13 | 2021–2024 |
| CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) | 12 | 2023–2026 |
| NATIONAL AIR TRAFFIC CONTROLLERS ASSOCIATION | 12 | 2017–2019 |
| ORLANDO ECONOMIC PARTNERSHIP | 12 | 2020–2023 |
| U.S. TRAVEL ASSOCIATION | 12 | 2014–2017 |
| HAWK CORPORATION | 11 | 2005–2009 |
| IMPROVING MARKET ACCESS COALITION (IMAC) | 11 | 2024–2026 |
| KEMP PARTNERS | 11 | 2005–2009 |
| MONSTER GOVERNMENT SOLUTIONS | 11 | 2005–2008 |
| HELICON CHEMICAL COMPANY | 10 | 2024–2026 |
| M3 EAGLE L.L.C. | 10 | 2011–2013 |
| NATIONAL CUSTOMS BROKERS & FORWARDERS ASSOCIATION OF AMERICA INC | 10 | 2019–2021 |
| THERMO FISHER SCIENTIFIC | 10 | 2008–2010 |
| VERIS VISALIGN | 10 | 2014–2016 |
| A1 LITHIUM / ANSON RESOURCES | 9 | 2023–2024 |
| ACCENTURE LLP | 9 | 2007–2008 |
| ATLAS AIR WORLDWIDE HOLDINGS, INC. | 9 | 2017–2018 |
| BYD MOTORS INC. | 9 | 2017–2019 |
| CAROUSEL CENTER COMPANY, LP/DESTINY USA HOLDINGS, LLC | 9 | 2019–2021 |
| REDEMTECH, INC. | 9 | 2010–2012 |
| TARGET HOSPITALITY CORPORATION | 9 | 2020–2021 |
| WOODINGS INDUSTRIAL CORPORATION | 8 | 2025–2026 |
| AMERICAN ROAD & TRANSPORTATION BUILDERS ASSOCIATION (ARTBA) | 7 | 2005–2007 |
| DUXBURY FINANCIAL, LLC | 7 | 2008–2010 |
| EXCELITAS TECHNOLOGIES CORP. | 7 | 2025–2026 |
| ACUSENSUS INC. | 6 | 2020–2021 |
| AHIP | 6 | 2025–2026 |
| APPLIED PERSPECTIVE (FORMERLY FILED AS THOMAS GERRY BUFKIN) | 6 | 2010–2011 |
| DATA MACHINES | 6 | 2025–2026 |
| DOCUSIGN | 6 | 2019–2020 |
| MES FIRE | 6 | 2020–2021 |
| MOMENT ENERGY | 6 | 2025–2026 |
| NATIONAL TRANSPORTATION COALITION | 6 | 2013–2014 |
| PENSKE TRUCK LEASING | 6 | 2005–2007 |
| RAVN ALASKA | 6 | 2018–2019 |
| THERMAL FLEX INSULATION, LLC | 6 | 2009–2010 |
| UNITHREE INVESTMENT CORPORATION | 6 | 2007–2008 |
| YOUSCRIPT | 6 | 2019–2020 |
| AMERICAN CLEANING INSTITUTE | 5 | 2023 |
| AMERICAN SHORT LINE AND REGIONAL RAILROAD ASSOCIATION | 5 | 2017 |
| FISHER-TITUS MEDICAL CENTER | 5 | 2009–2010 |
| METRO TECH PARTNERS LLC | 5 | 2008–2009 |
| XYLEM | 5 | 2023–2024 |
| AMERICAN TEXTILE COMPANY | 4 | 2018 |
| ASSOCIATION OF EQUIPMENT MANUFACTURERS | 4 | 2020 |
| AVONDALE VENTURES, LLC | 4 | 2011–2012 |
| BAUM ENVIRONMENTAL GROUP | 4 | 2018–2019 |
| BPL GLOBAL, LTD | 4 | 2009 |
| CARTERSVILLE-BARTOW COUNTY CHAMBER OF COMMERCE | 4 | 2014 |
| CITY OF MESA - ARIZONA | 4 | 2009–2010 |
| FORTRESS INFORMATION SECURITY | 4 | 2020 |
| FULLCIRCLE GEOSOCIAL NETWORK, INC. | 4 | 2013 |
| INCCOMMUNICATIONS SERVICES, INC. | 4 | 2015–2016 |
| PANACEA GLOBAL ENERGY | 4 | 2023–2024 |
| PAYSAFE PAYMENT PROCESSING SOLUTIONS, LLC | 4 | 2026 |
| THE FINTECH ACCORD | 4 | 2026 |
| BLACKLIDGE ASPHALT SUPPLY | 3 | 2023 |
| BRUNS-PAK | 3 | 2017 |
| CALYX, LLC | 3 | 2019 |
| CARELINK HOME HEALTH | 3 | 2024 |
| ECHOSTAR SATELLITE LLC | 3 | 2006 |
| GULF COAST ASPHALT CO | 3 | 2005 |
| HAWAII ISLAND AIR, INC. | 3 | 2015 |
| HILL & ROBBINS | 3 | 2005–2006 |
| M.M. HAYES CO., INC. | 3 | 2013 |
Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 3014 Ensuring Timely Access to Generics Act of 2025 S. 1414 Expedited Access to Biosimilars Act S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 3014 Ensuring Timely Access to Generics Act of 2025 S. 1414 Expedited Access to Biosimilars Act S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 3014 Ensuring Timely Access to Generics Act of 2025 S. 1414 Expedited Access to Biosimilars Act S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Protecting Access to Ground Ambulance Medical Services Act of 2025
Client: SARNOVA, LLC · Firm: WHITMER & WORRALL, LLC
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Protecting Access to Ground Ambulance Medical Services Act of 2025
Client: SARNOVA, LLC · Firm: WHITMER & WORRALL, LLC
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Protecting Access to Ground Ambulance Medical Services Act of 2025
Client: SARNOVA, LLC · Firm: WHITMER & WORRALL, LLC
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Portable Ultrasound Reimbursement Equity Act of 2025
Client: TRIDENTCARE · Firm: WHITMER & WORRALL, LLC
Issues related to Medicare reimbursement levels, portable x-ray services and ultrasounds for long-term care residents. Issues related to clinical laboratory and x-ray technician staffing shortages. Issues related to HR. 2477, the Portable Ultrasound Reimbursement Equity (PURE) Act. Issues related to S. 1168, the Portable Ultrasound Reimbursement Equity (PURE) Act.
Portable Ultrasound Reimbursement Equity Act of 2025
Client: TRIDENTCARE · Firm: WHITMER & WORRALL, LLC
Issues related to Medicare reimbursement levels, portable x-ray services and ultrasounds for long-term care residents. Issues related to clinical laboratory and x-ray technician staffing shortages. Issues related to HR. 2477, the Portable Ultrasound Reimbursement Equity (PURE) Act. Issues related to S. 1168, the Portable Ultrasound Reimbursement Equity (PURE) Act.
Portable Ultrasound Reimbursement Equity Act of 2025
Client: TRIDENTCARE · Firm: WHITMER & WORRALL, LLC
Issues related to Medicare reimbursement levels, portable x-ray services and ultrasounds for long-term care residents. Issues related to clinical laboratory and x-ray technician staffing shortages. Issues related to HR. 2477, the Portable Ultrasound Reimbursement Equity (PURE) Act. Issues related to S. 1168, the Portable Ultrasound Reimbursement Equity (PURE) Act.
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Secure E-Waste Export and Recycling Act
Client: COALITION FOR AMERICAN ELECTRONICS RECYCLING · Firm: WHITMER & WORRALL, LLC
Issues related to E-waste and national security, including counterfeiting parts within the semiconductor industry. Issues related to H.R. 2998, The Secure E-Waste Export and Recycling Act. Issues related to sourcing critical minerals from E-waste recycling.
Secure E-Waste Export and Recycling Act
Client: COALITION FOR AMERICAN ELECTRONICS RECYCLING · Firm: WHITMER & WORRALL, LLC
Issues related to E-waste and national security, including counterfeiting parts within the semiconductor industry. Issues related to H.R. 2998, The Secure E-Waste Export and Recycling Act. Issues related to sourcing critical minerals from E-waste recycling.
Secure E-Waste Export and Recycling Act
Client: COALITION FOR AMERICAN ELECTRONICS RECYCLING · Firm: WHITMER & WORRALL, LLC
Issues related to E-waste and national security, including counterfeiting parts within the semiconductor industry. Issues related to H.R. 2998, the Secure E-Waste Export and Recycling Act.
Secure E-Waste Export and Recycling Act
Client: COALITION FOR AMERICAN ELECTRONICS RECYCLING · Firm: WHITMER & WORRALL, LLC
Issues related to E-waste and national security, including counterfeiting parts within the semiconductor industry. Issues related to H.R. 2998, The Secure E-Waste Export and Recycling Act. Issues related to sourcing critical minerals from E-waste recycling.
Secure E-Waste Export and Recycling Act
Client: COALITION FOR AMERICAN ELECTRONICS RECYCLING · Firm: WHITMER & WORRALL, LLC
Issues related to E-waste and national security, including counterfeiting parts within the semiconductor industry. Issues related to H.R. 2998, the Secure E-Waste Export and Recycling Act.
Secure E-Waste Export and Recycling Act
Client: COALITION FOR AMERICAN ELECTRONICS RECYCLING · Firm: WHITMER & WORRALL, LLC
Issues related to E-waste and national security, including counterfeiting parts within the semiconductor industry. Issues related to H.R. 2998, the Secure E-Waste Export and Recycling Act.
No Handouts for Drug Advertisements Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
S. 1785 & H.R. 3010, the No Handouts for Drug Advertisements Act.
No Handouts for Drug Advertisements Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
S. 1785 & H.R. 3010, the No Handouts for Drug Advertisements Act.
Patent Eligibility Restoration Act of 2025
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Patent Eligibility Restoration Act of 2025
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
PREVAIL Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
PREVAIL Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
ETHIC Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
ETHIC Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Digital Asset Market Clarity Act
Client: PAYSAFE PAYMENT PROCESSING SOLUTIONS, LLC · Firm: WHITMER & WORRALL, LLC
Issues related to S. 394, the GENIUS Act of 2025. Issues related to the Congressional FinTech and Payments Caucus. Issues related to artificial intelligence and payments. Issues related to H.R. 3633, the Digital Asset Market Clarity Act of 2025.
Issues related to S. 394, the GENIUS Act of 2025. Issues related to the Congressional FinTech and Payments Caucus. Issues related to artificial intelligence and payments. Issues related to H.R. 3633, the Digital Asset Market Clarity Act of 2025.
Issues related to S. 394, the GENIUS Act of 2025. Issues related to the Congressional FinTech and Payments Caucus. Issues related to artificial intelligence and payments. Issues related to H.R. 3633, the Digital Asset Market Clarity Act of 2025.
Digital Asset Market Clarity Act
Client: PAYSAFE PAYMENT PROCESSING SOLUTIONS, LLC · Firm: WHITMER & WORRALL, LLC
Issues related to S. 394, the GENIUS Act of 2025. Issues related to the Congressional FinTech and Payments Caucus. Issues related to artificial intelligence and payments. Issues related to H.R. 3633, the Digital Asset Market Clarity Act of 2025.
Digital Asset Market Clarity Act
Client: PAYSAFE PAYMENT PROCESSING SOLUTIONS, LLC · Firm: WHITMER & WORRALL, LLC
Issues related to S. 394, the GENIUS Act of 2025. Issues related to the Congressional FinTech and Payments Caucus. Issues related to artificial intelligence and payments. Issues related to H.R. 3633, the Digital Asset Market Clarity Act of 2025.
Issues related to S. 394, the GENIUS Act of 2025. Issues related to the Congressional FinTech and Payments Caucus. Issues related to artificial intelligence and payments. Issues related to H.R. 3633, the Digital Asset Market Clarity Act of 2025.
DTC Act of 2025
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Issues related to prescription drug prices. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S.229 DTC Act of 2025.
DTC Act of 2025
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Issues related to prescription drug prices. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S.229 DTC Act of 2025.
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Client: GHOSTWORKS MARINE · Firm: WHITMER & WORRALL, LLC
Issues related to H.R.3838, the Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026.
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Client: HELICON CHEMICAL COMPANY · Firm: WHITMER & WORRALL, LLC
Issues related to solid rocket motor production. Issues related to S. 4638, the National Defense Authorization Act for Fiscal Year 2025. Issues related to H.R. 8070, the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025. Issues related to the National Defense Authorization Act for Fiscal Year 2026. Issues related to H.R. 4016 and S. 2572, the Department of Defense Appropriations Act, 2026 Issues related to H.R. 3838, the SPEED Act. Issues related to S. 2296, the National Defense Authorization Act for Fiscal Year 2026.
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Client: DATA MACHINES · Firm: WHITMER & WORRALL, LLC
Issues related to the National Defense Authorization Act for Fiscal Year 2027. Issues related to H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026.
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Client: HELICON CHEMICAL COMPANY · Firm: WHITMER & WORRALL, LLC
Issues related to the National Defense Authorization Act for Fiscal Year 2027. Issues related to H.R. 3838, the SPEED Act. Issues related to S. 2296, the National Defense Authorization Act for Fiscal Year 2027.
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Client: DATA MACHINES · Firm: WHITMER & WORRALL, LLC
Issues related to modeling and simulation and defense operational research applications. Issues related to H.R. 3838, the SPEED Act. Issues related to the Department of Defense Appropriations Act, 2027.
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Department of Defense Appropriations Act, 2026
Client: HELICON CHEMICAL COMPANY · Firm: WHITMER & WORRALL, LLC
Issues related to solid rocket motor production. Issues related to S. 4638, the National Defense Authorization Act for Fiscal Year 2025. Issues related to H.R. 8070, the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025. Issues related to the National Defense Authorization Act for Fiscal Year 2026. Issues related to H.R. 4016 and S. 2572, the Department of Defense Appropriations Act, 2026 Issues related to H.R. 3838, the SPEED Act. Issues related to S. 2296, the National Defense Authorization Act for Fiscal Year 2026.
Interagency Patent Coordination and Improvement Act of 2025
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Interagency Patent Coordination and Improvement Act of 2025
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Biosimilar Red Tape Elimination Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 3014 Ensuring Timely Access to Generics Act of 2025 S. 1414 Expedited Access to Biosimilars Act S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act
Biosimilar Red Tape Elimination Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 3014 Ensuring Timely Access to Generics Act of 2025 S. 1414 Expedited Access to Biosimilars Act S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act
Skinny Labels, Big Savings Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Skinny Labels, Big Savings Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Emergency Medical Services Reimbursement for On-Scene and Support Act
Client: SARNOVA, LLC · Firm: WHITMER & WORRALL, LLC
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Emergency Medical Services Reimbursement for On-Scene and Support Act
Client: SARNOVA, LLC · Firm: WHITMER & WORRALL, LLC
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Emergency Medical Services Reimbursement for On-Scene and Support Act
Client: SARNOVA, LLC · Firm: WHITMER & WORRALL, LLC
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Child Suicide Prevention Act
Client: HELICON CHEMICAL COMPANY · Firm: WHITMER & WORRALL, LLC
Issues related to solid rocket motor production. Issues related to S. 4638, the National Defense Authorization Act for Fiscal Year 2025. Issues related to H.R. 8070, the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025. Issues related to the National Defense Authorization Act for Fiscal Year 2026. Issues related to H.R. 4016 and S. 2572, the Department of Defense Appropriations Act, 2026 Issues related to H.R. 3838, the SPEED Act. Issues related to S. 2296, the National Defense Authorization Act for Fiscal Year 2026.
Major Richard Star Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 3014 Ensuring Timely Access to Generics Act of 2025 S. 1414 Expedited Access to Biosimilars Act S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act
Major Richard Star Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 3014 Ensuring Timely Access to Generics Act of 2025 S. 1414 Expedited Access to Biosimilars Act S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act
Drug Competition Enhancement Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Drug Competition Enhancement Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Affordable Prescriptions for Patients Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Affordable Prescriptions for Patients Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Stop STALLING Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 3014 Ensuring Timely Access to Generics Act of 2025 S. 1414 Expedited Access to Biosimilars Act S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act
Stop STALLING Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 3014 Ensuring Timely Access to Generics Act of 2025 S. 1414 Expedited Access to Biosimilars Act S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act
Preserve Access to Affordable Generics and Biosimilars Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Preserve Access to Affordable Generics and Biosimilars Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Interagency Patent Coordination and Improvement Act of 2025
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Interagency Patent Coordination and Improvement Act of 2025
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Portable Ultrasound Reimbursement Equity Act of 2025
Client: TRIDENTCARE · Firm: WHITMER & WORRALL, LLC
Issues related to Medicare reimbursement levels, portable x-ray services and ultrasounds for long-term care residents. Issues related to clinical laboratory and x-ray technician staffing shortages. Issues related to HR. 2477, the Portable Ultrasound Reimbursement Equity (PURE) Act. Issues related to S. 1168, the Portable Ultrasound Reimbursement Equity (PURE) Act.
Portable Ultrasound Reimbursement Equity Act of 2025
Client: TRIDENTCARE · Firm: WHITMER & WORRALL, LLC
Issues related to Medicare reimbursement levels, portable x-ray services and ultrasounds for long-term care residents. Issues related to clinical laboratory and x-ray technician staffing shortages. Issues related to HR. 2477, the Portable Ultrasound Reimbursement Equity (PURE) Act. Issues related to S. 1168, the Portable Ultrasound Reimbursement Equity (PURE) Act.
Portable Ultrasound Reimbursement Equity Act of 2025
Client: TRIDENTCARE · Firm: WHITMER & WORRALL, LLC
Issues related to Medicare reimbursement levels, portable x-ray services and ultrasounds for long-term care residents. Issues related to clinical laboratory and x-ray technician staffing shortages. Issues related to HR. 2477, the Portable Ultrasound Reimbursement Equity (PURE) Act. Issues related to S. 1168, the Portable Ultrasound Reimbursement Equity (PURE) Act.
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Expedited Access to Biosimilars Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 3014 Ensuring Timely Access to Generics Act of 2025 S. 1414 Expedited Access to Biosimilars Act S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act
Expedited Access to Biosimilars Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 3014 Ensuring Timely Access to Generics Act of 2025 S. 1414 Expedited Access to Biosimilars Act S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act
A bill to amend title 38, United States Code, to make permanent and codify the pilot program for use of contract physicians for disability examinations, and for other purposes.
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
A bill to amend title 38, United States Code, to make permanent and codify the pilot program for use of contract physicians for disability examinations, and for other purposes.
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Patent Eligibility Restoration Act of 2025
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Patent Eligibility Restoration Act of 2025
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Protecting Access to Ground Ambulance Medical Services Act of 2025
Client: SARNOVA, LLC · Firm: WHITMER & WORRALL, LLC
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Protecting Access to Ground Ambulance Medical Services Act of 2025
Client: SARNOVA, LLC · Firm: WHITMER & WORRALL, LLC
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Protecting Access to Ground Ambulance Medical Services Act of 2025
Client: SARNOVA, LLC · Firm: WHITMER & WORRALL, LLC
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
No Handouts for Drug Advertisements Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
S. 1785 & H.R. 3010, the No Handouts for Drug Advertisements Act.
No Handouts for Drug Advertisements Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
S. 1785 & H.R. 3010, the No Handouts for Drug Advertisements Act.
Biosimilar Red Tape Elimination Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 3014 Ensuring Timely Access to Generics Act of 2025 S. 1414 Expedited Access to Biosimilars Act S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act
Biosimilar Red Tape Elimination Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 3014 Ensuring Timely Access to Generics Act of 2025 S. 1414 Expedited Access to Biosimilars Act S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act
ETHIC Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
ETHIC Act
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
DTC Act of 2025
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Issues related to prescription drug prices. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S.229 DTC Act of 2025.
DTC Act of 2025
Client: CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · Firm: WHITMER & WORRALL, LLC
Issues related to prescription drug prices. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S.229 DTC Act of 2025.
National Defense Authorization Act for Fiscal Year 2026
Client: HELICON CHEMICAL COMPANY · Firm: WHITMER & WORRALL, LLC
Issues related to solid rocket motor production. Issues related to S. 4638, the National Defense Authorization Act for Fiscal Year 2025. Issues related to H.R. 8070, the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025. Issues related to the National Defense Authorization Act for Fiscal Year 2026. Issues related to H.R. 4016 and S. 2572, the Department of Defense Appropriations Act, 2026 Issues related to H.R. 3838, the SPEED Act. Issues related to S. 2296, the National Defense Authorization Act for Fiscal Year 2026.
National Defense Authorization Act for Fiscal Year 2026
Client: HELICON CHEMICAL COMPANY · Firm: WHITMER & WORRALL, LLC
Issues related to the National Defense Authorization Act for Fiscal Year 2027. Issues related to H.R. 3838, the SPEED Act. Issues related to S. 2296, the National Defense Authorization Act for Fiscal Year 2027.
Issues related to S. 394, the GENIUS Act of 2025. Issues related to the Congressional FinTech and Payments Caucus. Issues related to artificial intelligence and payments. Issues related to H.R. 3633, the Digital Asset Market Clarity Act of 2025.
Issues related to the U.S. financial services transaction and payments processing industry, including cybersecurity.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXCELITAS TECHNOLOGIES CORP. via WHITMER & WORRALL, LLC
2026 · third_quarter · Q3
Issues related to life sciences, advanced manufacturing, and semiconductor technology.
Issues related to international trade and tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WOODINGS INDUSTRIAL CORPORATION via WHITMER & WORRALL, LLC
2026 · third_quarter · Q3
Issues related to international trade and tariffs on foreign steel imports.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
EUROFINS TRANSPLANT GENOMICS INC. via WHITMER & WORRALL, LLC
2026 · third_quarter · Q3
Issues related to CMS coverage of molecular diagnostics testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
IMPROVING MARKET ACCESS COALITION (IMAC) via WHITMER & WORRALL, LLC
2026 · third_quarter · Q3
Issues related to international trade and fumigation technology and services.
Issues related to international trade and fumigation technology and services. Issues related to non-tariff trade barriers with the European Union.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
SARNOVA, LLC via WHITMER & WORRALL, LLC
2026 · third_quarter · Q3
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Issues surrounding tariffs on EMS and pharmaceutical industry products, including medical supplies.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
TRIDENTCARE via WHITMER & WORRALL, LLC
2026 · third_quarter · Q3
Issues related to Medicare reimbursement levels, portable x-ray services and ultrasounds for long-term care residents. Issues related to clinical laboratory and x-ray technician staffing shortages. Issues related to HR. 2477, the Portable Ultrasound Reimbursement Equity (PURE) Act. Issues related to S. 1168, the Portable Ultrasound Reimbursement Equity (PURE) Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROTECH HEALTHCARE INC. via WHITMER & WORRALL, LLC
2026 · third_quarter · Q3
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR AMERICAN ELECTRONICS RECYCLING via WHITMER & WORRALL, LLC
2026 · third_quarter · Q3
Issues related to E-waste and national security, including counterfeiting parts within the semiconductor industry. Issues related to H.R. 2998, The Secure E-Waste Export and Recycling Act. Issues related to sourcing critical minerals from E-waste recycling.
Issues related to E-waste and national security, including counterfeiting parts within the semiconductor industry. Issues related to H.R. 2998, the Secure E-Waste Export and Recycling Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INDIANA REGIONAL MEDICAL CENTER via WHITMER & WORRALL, LLC
2026 · third_quarter · Q3
Issues related to rural healthcare delivery.
Issues related to rural healthcare delivery in Fiscal Year 2027 appropriations bills. Issues related to the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMMUNITY COLLEGE OF ALLEGHENY COUNTY (CCAC) via WHITMER & WORRALL, LLC
2026 · third_quarter · Q3
Issues related to higher education and community colleges and workforce training initiatives. Issues related to apprenticeship programs. Issues related to the nursing shortage.
Issues related to veterans benefit programs and education opportunities.
Issues related to the Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations, 2027. Issues related to the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, 2027.
THE FINTECH ACCORD via WHITMER & WORRALL, LLC
2026 · second_quarter · Q2
Issues related to S. 394, the GENIUS Act of 2025. Issues related to the Congressional FinTech and Payments Caucus. Issues related to artificial intelligence and payments. Issues related to H.R. 3633, the Digital Asset Market Clarity Act of 2025.
Issues related to the U.S. financial services transaction and payments processing industry, including cybersecurity.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AHIP via WHITMER & WORRALL, LLC
2026 · second_quarter · 2T
Issues related to prescription drug pricing.
Issues related to prescription drug pricing.
Issues related to prescription drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PAYSAFE PAYMENT PROCESSING SOLUTIONS, LLC via WHITMER & WORRALL, LLC
2026 · second_quarter · Q2
Issues related to the U.S. financial services transaction and payments processing industry, including cybersecurity.
Issues related to S. 394, the GENIUS Act of 2025. Issues related to the Congressional FinTech and Payments Caucus. Issues related to artificial intelligence and payments. Issues related to H.R. 3633, the Digital Asset Market Clarity Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXCELITAS TECHNOLOGIES CORP. via WHITMER & WORRALL, LLC
2026 · second_quarter · Q2
Issues related to international trade and tariffs.
Issues related to life sciences, advanced manufacturing, and semiconductor technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WOODINGS INDUSTRIAL CORPORATION via WHITMER & WORRALL, LLC
2026 · second_quarter · Q2
Issues related to international trade and tariffs on foreign steel imports.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
EUROFINS TRANSPLANT GENOMICS INC. via WHITMER & WORRALL, LLC
2026 · second_quarter · Q2
Issues related to CMS coverage of molecular diagnostics testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) via WHITMER & WORRALL, LLC
2026 · second_quarter · 2T
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Issues related to prescription drug prices. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S.229 DTC Act of 2025.
IMPROVING MARKET ACCESS COALITION (IMAC) via WHITMER & WORRALL, LLC
2026 · second_quarter · Q2
Issues related to international trade and fumigation technology and services. Issues related to non-tariff trade barriers with the European Union.
Issues related to international trade and fumigation technology and services.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
SMR AUTOMOTIVE SYSTEMS USA INC. via WHITMER & WORRALL, LLC
2026 · second_quarter · Q2
Issues related to international trade and tariffs.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
PANASONIC CORPORATION OF NORTH AMERICA via WHITMER & WORRALL, LLC
2026 · second_quarter · Q2
Issues related to data privacy. Issues related to artificial intelligence.
Issues related to innovative products and services to enhance environmental sustainability. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022. Issues related to critical minerals including domestic sourcing and supply chain.
Issues related to international trade and supply chain. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022. Issues related to tariffs.
SARNOVA, LLC via WHITMER & WORRALL, LLC
2026 · second_quarter · Q2
Issues surrounding tariffs on EMS and pharmaceutical industry products, including medical supplies.
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
TRIDENTCARE via WHITMER & WORRALL, LLC
2026 · second_quarter · Q2
Issues related to Medicare reimbursement levels, portable x-ray services and ultrasounds for long-term care residents. Issues related to clinical laboratory and x-ray technician staffing shortages. Issues related to HR. 2477, the Portable Ultrasound Reimbursement Equity (PURE) Act. Issues related to S. 1168, the Portable Ultrasound Reimbursement Equity (PURE) Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROTECH HEALTHCARE INC. via WHITMER & WORRALL, LLC
2026 · second_quarter · Q2
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR AMERICAN ELECTRONICS RECYCLING via WHITMER & WORRALL, LLC
2026 · second_quarter · Q2
Issues related to E-waste and national security, including counterfeiting parts within the semiconductor industry. Issues related to H.R. 2998, the Secure E-Waste Export and Recycling Act.
Issues related to E-waste and national security, including counterfeiting parts within the semiconductor industry. Issues related to H.R. 2998, The Secure E-Waste Export and Recycling Act. Issues related to sourcing critical minerals from E-waste recycling.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INDIANA REGIONAL MEDICAL CENTER via WHITMER & WORRALL, LLC
2026 · second_quarter · Q2
Issues related to rural healthcare delivery in Fiscal Year 2027 appropriations bills. Issues related to the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027.
Issues related to rural healthcare delivery.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GEOSYNTHETIC MATERIALS ASSOCIATION - ATA (FORMERLY KNOWN AS GMA - IFAI) via WHITMER & WORRALL, LLC
2026 · second_quarter · Q2
Issues related to the implementation of H.R. 3684, the Infrastructure Investment and Jobs Act (IIJA). Issues related to Buy America. Issues related to energy and environmental permitting reform. Issues related to permitting reform in H.R. 1, the Lower Energy Costs Act. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022.
Issues related to promoting the use of geosynthetic materials in civil infrastructure, including aviation infrastructure. Issues related to the implementation of H.R. 3684, the the Infrastructure Investment and Jobs Act (IIJA). Issues related to Buy America. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022. Issues related to surface transportation reauthorization. Issues related to the Geosynthetic Materials Caucus.
COMMUNITY COLLEGE OF ALLEGHENY COUNTY (CCAC) via WHITMER & WORRALL, LLC
2026 · second_quarter · Q2
Issues related to higher education and community colleges. Issues related to access, equity, and diversity in education and the STEM pipeline. Issues related to pell grants.
Issues related to the Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations, 2027. Issues related to the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, 2027.
Issues related to veterans benefit programs and education opportunities.
SKYVEN TECHNOLOGIES via WHITMER & WORRALL, LLC
2026 · second_quarter · 2T
Grants related to industrial steam-generating heat pumps.
Grants related to industrial steam-generating heat pumps.
Grants related to industrial steam-generating heat pumps.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE, White House Office
PAYSAFE PAYMENT PROCESSING SOLUTIONS, LLC via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to S. 394, the GENIUS Act of 2025. Issues related to the Congressional FinTech and Payments Caucus. Issues related to artificial intelligence and payments. Issues related to H.R. 3633, the Digital Asset Market Clarity Act of 2025.
Issues related to the U.S. financial services transaction and payments processing industry, including cybersecurity.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE FINTECH ACCORD via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to S. 394, the GENIUS Act of 2025. Issues related to the Congressional FinTech and Payments Caucus. Issues related to artificial intelligence and payments. Issues related to H.R. 3633, the Digital Asset Market Clarity Act of 2025.
Issues related to the U.S. financial services transaction and payments processing industry, including cybersecurity.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIMEAI, INC. via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to artificial intelligence as a service and contracting opportunities.
Issues related to artificial intelligence as a service and contracting opportunities
Issues related to artificial intelligence as a service and contracting opportunities
AHIP via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to prescription drug pricing.
Issues related to prescription drug pricing.
Issues related to prescription drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXCELITAS TECHNOLOGIES CORP. via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to international trade and tariffs.
Issues related to life sciences, advanced manufacturing, and semiconductor technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOMENT ENERGY via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to 45X, 48C, and 48E tax credits. Issues related to the Inflation Reduction Act of 2022.
Issues related to related to FY27 appropriations legislation
Issues related to battery repurposing, energy storage, and grid resiliency. Issues related to Department of Energy (DOE) grants. Issues related to U.S. energy security and domestic job creation. Issues related to mitigating foreign reliance on critical minerals.
Filing targets: Federal Energy Regulatory Commission (FERC), HOUSE OF REPRESENTATIVES, SENATE
DATA MACHINES via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to the National Defense Authorization Act for Fiscal Year 2027. Issues related to H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026.
Issues related to modeling and simulation and defense operational research applications. Issues related to H.R. 3838, the SPEED Act. Issues related to the Department of Defense Appropriations Act, 2027.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WOODINGS INDUSTRIAL CORPORATION via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to international trade and tariffs on foreign steel imports.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
HELICON CHEMICAL COMPANY via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issue related to HTPB manufacturing. Issues related to advanced composite materials manufacturing.
Issues related to advanced propellants.
Issues related to solid rocket motor production. Issues related to S. 4638, the National Defense Authorization Act for Fiscal Year 2025. Issues related to H.R. 8070, the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025. Issues related to the National Defense Authorization Act for Fiscal Year 2026. Issues related to H.R. 4016 and S. 2572, the Department of Defense Appropriations Act, 2026 Issues related to H.R. 3838, the SPEED Act. Issues related to S. 2296, the National Defense Authorization Act for Fiscal Year 2026.
EUROFINS TRANSPLANT GENOMICS INC. via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to CMS coverage of molecular diagnostics testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to prescription drug prices. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S.229 DTC Act of 2025.
S. 1785 & H.R. 3010, the No Handouts for Drug Advertisements Act.
Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 3014 Ensuring Timely Access to Generics Act of 2025 S. 1414 Expedited Access to Biosimilars Act S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act
GHOSTWORKS MARINE via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to homeland security, transportation, and innovative marine vessel design and capabilities. Issues related to ice breaking technologies.
Issues related to homeland security, transportation, and innovative marine vessel design and capabilities. Issues related to ice breaking technologies. Issues related to the fast ferries programs. Issues related to ATTAIN grants. Issues related to port infrastructure. Issues related to FTA ferry grant projects. Issues related to surface transportation reauthorization.
Issues related to the Department of Defense Appropriations Act, 2027. Issues related to the Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027. Issues related to the Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027. Issues related to the Department of Homeland Security Appropriations Act, 2027.
IMPROVING MARKET ACCESS COALITION (IMAC) via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to international trade and fumigation technology and services.
Issues related to international trade and fumigation technology and services. Issues related to non-tariff trade barriers with the European Union.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
SMR AUTOMOTIVE SYSTEMS USA INC. via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to international trade and tariffs.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
PANASONIC CORPORATION OF NORTH AMERICA via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to the implementation of H.R. 3684, the Infrastructure Investment and Jobs Act (IIJA). Issues related to electric vehicles and battery technology. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022. Issues related to domestic critical mineral supply.
Issues related to data privacy. Issues related to artificial intelligence.
Issues related to international trade and supply chain. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022. Issues related to tariffs.
SARNOVA, LLC via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues surrounding tariffs on EMS and pharmaceutical industry products, including medical supplies.
Issues related to H.R. 2538 & S. 3145, the CARE Act of 2025. Issues related to H.R. 7277 & S. 3730, the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
TRIDENTCARE via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to Medicare reimbursement levels, portable x-ray services and ultrasounds for long-term care residents. Issues related to clinical laboratory and x-ray technician staffing shortages. Issues related to HR. 2477, the Portable Ultrasound Reimbursement Equity (PURE) Act. Issues related to S. 1168, the Portable Ultrasound Reimbursement Equity (PURE) Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROTECH HEALTHCARE INC. via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR AMERICAN ELECTRONICS RECYCLING via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to E-waste and national security, including counterfeiting parts within the semiconductor industry. Issues related to H.R. 2998, the Secure E-Waste Export and Recycling Act.
Issues related to E-waste and national security, including counterfeiting parts within the semiconductor industry. Issues related to H.R. 2998, The Secure E-Waste Export and Recycling Act. Issues related to sourcing critical minerals from E-waste recycling.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INDIANA REGIONAL MEDICAL CENTER via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to rural healthcare delivery in Fiscal Year 2027 appropriations bills. Issues related to the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027.
Issues related to rural healthcare delivery.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GEOSYNTHETIC MATERIALS ASSOCIATION - ATA (FORMERLY KNOWN AS GMA - IFAI) via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to promoting the use of geosynthetic materials in civil infrastructure, including aviation infrastructure. Issues related to the implementation of H.R. 3684, the the Infrastructure Investment and Jobs Act (IIJA). Issues related to Buy America. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022. Issues related to surface transportation reauthorization. Issues related to the Geosynthetic Materials Caucus.
Issues related to the implementation of H.R. 3684, the Infrastructure Investment and Jobs Act (IIJA). Issues related to Buy America. Issues related to energy and environmental permitting reform. Issues related to permitting reform in H.R. 1, the Lower Energy Costs Act. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022.
COMMUNITY COLLEGE OF ALLEGHENY COUNTY (CCAC) via WHITMER & WORRALL, LLC
2026 · first_quarter · Q1
Issues related to veterans benefit programs and education opportunities.
Issues related to higher education and community colleges. Issues related to access, equity, and diversity in education and the STEM pipeline. Issues related to pell grants.
Issues related to higher education and community colleges and workforce training initiatives. Issues related to apprenticeship programs. Issues related to the nursing shortage.
SKYVEN TECHNOLOGIES via WHITMER & WORRALL, LLC
2026 · first_quarter · RR
Grants related to industrial steam-generating heat pumps.
Grants related to industrial steam-generating heat pumps.
Grants related to industrial steam-generating heat pumps.
THE FINTECH ACCORD via WHITMER & WORRALL, LLC
2026 · first_quarter · RR
Issues related to the financial technology and digital asset industries.
Issues related to the financial technology and digital asset industries.
PAYSAFE PAYMENT PROCESSING SOLUTIONS, LLC via WHITMER & WORRALL, LLC
2026 · first_quarter · RR
Issues related to the U.S. financial services transaction and payment processing industry.
PRIMEAI, INC. via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to artificial intelligence as a service and contracting opportunities.
Issues related to artificial intelligence as a service and contracting opportunities.
Issues related to artificial intelligence as a service and contracting opportunities
AHIP via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to prescription drug pricing.
Issues related to prescription drug pricing.
Issues related to prescription drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXCELITAS TECHNOLOGIES CORP. via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to international trade and tariffs.
Issues related to life sciences, advanced manufacturing, and semiconductor technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOMENT ENERGY via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to related to FY26 appropriations legislation
Issues related to 45X, 48C, and 48E tax credits. Issues related to the Inflation Reduction Act of 2022.
Issues related to battery repurposing, energy storage, and grid resiliency. Issues related to Department of Energy (DOE) grants. Issues related to U.S. energy security and domestic job creation. Issues related to mitigating foreign reliance on critical minerals.
Filing targets: Federal Energy Regulatory Commission (FERC), HOUSE OF REPRESENTATIVES, SENATE
DATA MACHINES via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to modeling and simulation and defense operational research applications. Issues related to H.R. 3838, the SPEED Act. Issues related to H.R. 4016, the Department of Defense Appropriations Act, 2026.
Issues related to S. 2296, the National Defense Authorization Act for Fiscal Year 2026. Issues related to H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WOODINGS INDUSTRIAL CORPORATION via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to international trade and tariffs on foreign steel imports.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
HELICON CHEMICAL COMPANY via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to the National Defense Authorization Act for Fiscal Year 2026. Issues related to H.R. 3838, the SPEED Act. Issues related to S. 2296, the National Defense Authorization Act for Fiscal Year 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EUROFINS TRANSPLANT GENOMICS INC. via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to CMS coverage of molecular diagnostics testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to prescription drug prices. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S.229 DTC Act of 2025.
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
GHOSTWORKS MARINE via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to S. 2572 and H.R. 4016, the Department of Defense Appropriations Act, 2026. Issues related to H.R.5342 and S. 2354, the Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026. Issues related to H.R. 4552 and S. 2465, the Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026. Issues related to H.R. 4213, the Department of Homeland Security Appropriations Act, 2026.
Issues related to homeland security, transportation, and innovative marine vessel design and capabilities. Issues related to ice breaking technologies.
IMPROVING MARKET ACCESS COALITION (IMAC) via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to international trade and fumigation technology and services.
Issues related to international trade and fumigation technology and services. Issues related to non-tariff trade barriers with the European Union.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SMR AUTOMOTIVE SYSTEMS USA INC. via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to international trade and tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
PANASONIC CORPORATION OF NORTH AMERICA via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to the implementation of H.R. 3684, the Infrastructure Investment and Jobs Act (IIJA). Issues related to electric vehicles and battery technology. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022. Issues related to domestic critical mineral supply.
Issues related to international trade and supply chain. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022. Issues related to tariffs.
Issues related to corporate tax. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022.
SARNOVA, LLC via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to H.R. 2538, the CARE Act of 2025. Issues related to the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Issues surrounding tariffs on EMS and pharmaceutical industry products, including medical supplies.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
TRIDENTCARE via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to Medicare reimbursement levels, portable x-ray services and ultrasounds for long-term care residents. Issues related to clinical laboratory and x-ray technician staffing shortages. Issues related to HR. 2477, the Portable Ultrasound Reimbursement Equity (PURE) Act. Issues related to S. 1168, the Portable Ultrasound Reimbursement Equity (PURE) Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROTECH HEALTHCARE INC. via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN TRANSACTION PROCESSORS COALITION via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to S. 394, the GENIUS Act of 2025. Issues related to the Congressional FinTech and Payments Caucus. Issues related to the Senate Payments Innovation Caucus. Issues related to the House FinTech Task Force. Issues related to privacy and data breach notification. Issues related to FedNow and faster payments. Issues related to financial inclusion and the unbanked and underbanked. Issues related to Central Bank Digital Currencies (CBDC), stablecoins, and digital assets. Issues related to H.R. 1165, the Data Privacy Act of 2023. Issues related to the implementation of H.R. 4346, the Chips and Science Act. Issues related to the creation of a Merchant Category Code (MCC). Issues related to artificial intelligence and payments. Issues related to H.R. 2891 / S. 1323, the Secure And Fair Enforcement (SAFE) Banking Act of 2023. Issues related to H.R. 4763, the Financial Innovation and Technology for the 21st Century Act. Issues related to H.R. 4766, the Clarity for Payment Stablecoins Act of 2023. Issues related to S. 5242, the Saving Privacy Act. Issues related to H.R. 3633, the Digital Asset Market Clarity Act of 2025.
COALITION FOR AMERICAN ELECTRONICS RECYCLING via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to E-waste and national security, including counterfeiting parts within the semiconductor industry. Issues related to H.R. 2998, The Secure E-Waste Export and Recycling Act. Issues related to the Basel Convention. Issues related to sourcing critical minerals from E-waste recycling.
Issues related to E-waste and national security, including counterfeiting parts within the semiconductor industry. Issues related to H.R. 2998, the Secure E-Waste Export and Recycling Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INDIANA REGIONAL MEDICAL CENTER via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to rural healthcare delivery.
Issues related to rural healthcare delivery in Fiscal Year 2026 appropriations bills. Issues related to H.R. 9027, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GEOSYNTHETIC MATERIALS ASSOCIATION - ATA (FORMERLY KNOWN AS GMA - IFAI) via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to geosynthetic containment solutions for the energy industry. Issues related to energy and environmental permitting reform. Issues related to Buy America. Issues related to permitting reform in H.R. 1, the Lower Energy Costs Act. Issues related to the creation of the Geosynthetics Caucus.
Issues related to the implementation of H.R. 3684, the Infrastructure Investment and Jobs Act (IIJA). Issues related to Buy America. Issues related to energy and environmental permitting reform. Issues related to permitting reform in H.R. 1, the Lower Energy Costs Act. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022.
COMMUNITY COLLEGE OF ALLEGHENY COUNTY (CCAC) via WHITMER & WORRALL, LLC
2025 · fourth_quarter · Q4
Issues related to the Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations, 2026. Issues related to the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, 2026.
Issues related to veterans benefit programs and education opportunities.
Issues related to higher education and community colleges. Issues related to access, equity, and diversity in education and the STEM pipeline. Issues related to pell grants.
PRIMEAI, INC. via WHITMER & WORRALL, LLC
2025 · fourth_quarter · RR
Issues related to artificial intelligence as a service and contracting opportunities.
Issues related to artificial intelligence as a service and contracting opportunities.
Issues related to artificial intelligence as a service and contracting opportunities.
AHIP via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to prescription drug pricing.
Issues related to prescription drug pricing.
Issues related to prescription drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXCELITAS TECHNOLOGIES CORP. via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to international trade and tariffs.
Issues related to life sciences, advanced manufacturing, and semiconductor technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOMENT ENERGY via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to 45X, 48C, and 48E tax credits. Issues related to the Inflation Reduction Act of 2022.
Issues related to battery repurposing, energy storage, and grid resiliency. Issues related to Department of Energy (DOE) grants. Issues related to U.S. energy security and domestic job creation. Issues related to mitigating foreign reliance on critical minerals.
Issues related to related to FY26 appropriations legislation
Filing targets: Federal Energy Regulatory Commission (FERC), HOUSE OF REPRESENTATIVES, SENATE
DATA MACHINES via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to modeling and simulation and defense operational research applications. Issues related to H.R. 3838, the SPEED Act. Issues related to H.R. 4016, the Department of Defense Appropriations Act, 2026.
Issues related to S. 2296, the National Defense Authorization Act for Fiscal Year 2026. Issues related to H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WOODINGS INDUSTRIAL CORPORATION via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to international trade and tariffs on foreign steel imports.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
HELICON CHEMICAL COMPANY via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to the National Defense Authorization Act for Fiscal Year 2026. Issues related to H.R. 3838, the SPEED Act. Issues related to S. 2296, the National Defense Authorization Act for Fiscal Year 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EUROFINS TRANSPLANT GENOMICS INC. via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to CMS coverage of molecular diagnostics testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to prescription drug prices. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S.229 DTC Act of 2025. Issues related to H.R. 1, One Big Beautiful Bill Act.
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. S.43 Skinny Labels, Big Savings Act. H.R. 5526/S. 1954, the Biosimilar Red Tape Elimination Act. S. 1785 & H.R. 3010, the No Handouts for Drug Advertisements Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
GHOSTWORKS MARINE via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to homeland security, transportation, and innovative marine vessel design and capabilities. Issues related to ice breaking technologies. Issues related to fast ferries programs.
Issues related to homeland security, transportation, and innovative marine vessel design and capabilities. Issues related to ice breaking technologies. Issues related to the fast ferries programs. Issues related to ATTAIN grants. Issues related to port infrastructure. Issues related to FTA ferry grant projects. Issues related to surface transportation reauthorization.
IMPROVING MARKET ACCESS COALITION (IMAC) via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to international trade and fumigation technology and services.
Issues related to international trade and fumigation technology and services. Issues related to non-tariff trade barriers with the European Union.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SMR AUTOMOTIVE SYSTEMS USA INC. via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to international trade and tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
PANASONIC CORPORATION OF NORTH AMERICA via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to the implementation of H.R. 3684, the Infrastructure Investment and Jobs Act (IIJA). Issues related to electric vehicles and battery technology. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022. Issues related to domestic critical mineral supply.
Issues related to international trade and supply chain. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022. Issues related to tariffs.
Issues related to corporate tax. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022.
SARNOVA, LLC via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to H.R. 2538, the CARE Act of 2025. Issues related to the Emergency Medical Services Reimbursement for On-Scene Care and Support Act. Issues related to H.R. 4011, the Community Paramedicine Act of 2025. Issues related to the Supporting Our First Responders Act. Issues related to H.R. 2220, the PARA-EMT Act of 2025. Issues related to H.R. 2232 & S. 1643, Protecting Access to Ground Ambulance Medical Services Act of 2025.
Issues surrounding tariffs on EMS and pharmaceutical industry products, including medical supplies.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
TRIDENTCARE via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to Medicare reimbursement levels, portable x-ray services and ultrasounds for long-term care residents. Issues related to clinical laboratory and x-ray technician staffing shortages. Issues related to HR. 2477, the Portable Ultrasound Reimbursement Equity (PURE) Act. Issues related to S. 1168, the Portable Ultrasound Reimbursement Equity (PURE) Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROTECH HEALTHCARE INC. via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN TRANSACTION PROCESSORS COALITION via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to S. 394, the GENIUS Act of 2025. Issues related to the Congressional FinTech and Payments Caucus. Issues related to the Senate Payments Innovation Caucus. Issues related to the House FinTech Task Force. Issues related to privacy and data breach notification. Issues related to FedNow and faster payments. Issues related to financial inclusion and the unbanked and underbanked. Issues related to Central Bank Digital Currencies (CBDC), stablecoins, and digital assets. Issues related to H.R. 1165, the Data Privacy Act of 2023. Issues related to the implementation of H.R. 4346, the Chips and Science Act. Issues related to the creation of a Merchant Category Code (MCC). Issues related to artificial intelligence and payments. Issues related to H.R. 2891 / S. 1323, the Secure And Fair Enforcement (SAFE) Banking Act of 2023. Issues related to H.R. 4763, the Financial Innovation and Technology for the 21st Century Act. Issues related to H.R. 4766, the Clarity for Payment Stablecoins Act of 2023. Issues related to S. 5242, the Saving Privacy Act. Issues related to H.R. 3633, the Digital Asset Market Clarity Act of 2025.
COALITION FOR AMERICAN ELECTRONICS RECYCLING via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to E-waste and national security, including counterfeiting parts within the semiconductor industry. Issues related to H.R. 2998, The Secure E-Waste Export and Recycling Act. Issues related to the Basel Convention. Issues related to sourcing critical minerals from E-waste recycling.
Issues related to E-waste and national security, including counterfeiting parts within the semiconductor industry. Issues related to H.R. 2998, the Secure E-Waste Export and Recycling Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INDIANA REGIONAL MEDICAL CENTER via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to rural healthcare delivery.
Issues related to rural healthcare delivery in Fiscal Year 2026 appropriations bills. Issues related to H.R. 9027, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GEOSYNTHETIC MATERIALS ASSOCIATION - ATA (FORMERLY KNOWN AS GMA - IFAI) via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to promoting the use of geosynthetic materials in civil infrastructure, including aviation infrastructure. Issues related to the implementation of H.R. 3684, the the Infrastructure Investment and Jobs Act (IIJA). Issues related to Buy America. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022. Issues related to surface transportation reauthorization.
Issues related to geosynthetic containment solutions for the energy industry. Issues related to energy and environmental permitting reform. Issues related to Buy America. Issues related to permitting reform in H.R. 1, the Lower Energy Costs Act. Issues related to the creation of the Geosynthetics Caucus.
COMMUNITY COLLEGE OF ALLEGHENY COUNTY (CCAC) via WHITMER & WORRALL, LLC
2025 · third_quarter · Q3
Issues related to higher education and community colleges. Issues related to access, equity, and diversity in education and the STEM pipeline. Issues related to pell grants.
Issues related to higher education and community colleges and workforce training initiatives. Issues related to apprenticeship programs. Issues related to the nursing shortage.
Issues related to the Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations, 2026. Issues related to the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, 2026.
AHIP via WHITMER & WORRALL, LLC
2025 · second_quarter · Q2
Issues related to prescription drug pricing.
Issues related to prescription drug pricing.
Issues related to prescription drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXCELITAS TECHNOLOGIES CORP. via WHITMER & WORRALL, LLC
2025 · second_quarter · Q2
Issues related to international trade and tariffs.
Issues related to life sciences, advanced manufacturing, and semiconductor technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOMENT ENERGY via WHITMER & WORRALL, LLC
2025 · second_quarter · Q2
Issues related to 45X, 48C, and 48E tax credits. Issues related to the Inflation Reduction Act of 2022.
Issues related to battery repurposing, energy storage, and grid resiliency. Issues related to Department of Energy (DOE) grants. Issues related to U.S. energy security and domestic job creation. Issues related to mitigating foreign reliance on critical minerals.
Issues related to related to FY26 appropriations legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to higher education and community colleges. Issues related to access, equity, and diversity in education and the STEM pipeline. Issues related to pell grants.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE
S. 1785 & H.R. 3010, the No Handouts for Drug Advertisements Act.
Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 3014 Ensuring Timely Access to Generics Act of 2025 S. 1414 Expedited Access to Biosimilars Act S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to corporate tax. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022.
Issues related to the implementation of H.R. 3684, the Infrastructure Investment and Jobs Act (IIJA). Issues related to electric vehicles and battery technology. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022. Issues related to domestic critical mineral supply.
Filing targets: Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to geosynthetic containment solutions for the energy industry. Issues related to energy and environmental permitting reform. Issues related to Buy America. Issues related to permitting reform in H.R. 1, the Lower Energy Costs Act. Issues related to the creation of the Geosynthetics Caucus.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
Issues related to higher education and community colleges and workforce training initiatives. Issues related to apprenticeship programs. Issues related to the nursing shortage.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE
Issues related to artificial intelligence as a service and contracting opportunities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the National Defense Authorization Act for Fiscal Year 2027. Issues related to H.R. 3838, the SPEED Act. Issues related to S. 2296, the National Defense Authorization Act for Fiscal Year 2027.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to H.R.3838, the Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026.
Issues related to homeland security, transportation, and innovative marine vessel design and capabilities. Issues related to ice breaking technologies. Issues related to fast ferries programs.
Issues related to offshore wind and oil / gas platforms and offshore energy infrastructure construction.
Filing targets: Federal Transit Administration (FTA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to corporate tax. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022.
Issues related to innovative products and services to enhance environmental sustainability. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022. Issues related to critical minerals including domestic sourcing and supply chain.
Filing targets: Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to geosynthetic containment solutions for the energy industry. Issues related to energy and environmental permitting reform. Issues related to Buy America. Issues related to permitting reform in H.R. 1, the Lower Energy Costs Act. Issues related to the creation of the Geosynthetics Caucus.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
Issues related to the Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations, 2027. Issues related to the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, 2027.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE
Issues related to artificial intelligence as a service and contracting opportunities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. Ensuring Timely Access to Generics Act. S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act
S. 1785 & H.R. 3010, the No Handouts for Drug Advertisements Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to homeland security, transportation, and innovative marine vessel design and capabilities. Issues related to ice breaking technologies. Issues related to fast ferries programs.
Issues related to homeland security, transportation, and innovative marine vessel design and capabilities. Issues related to ice breaking technologies. Issues related to the fast ferries programs. Issues related to ATTAIN grants. Issues related to port infrastructure. Issues related to FTA ferry grant projects. Issues related to surface transportation reauthorization.
Issues related to offshore wind and oil / gas platforms and offshore energy infrastructure construction.
Issues related to H. R. 8070, the Servicemember Quality of Life Improvement Act and National Defense Authorization Act for Fiscal Year 2025.
Filing targets: Federal Transit Administration (FTA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to innovative products and services to enhance environmental sustainability. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022. Issues related to critical minerals including domestic sourcing and supply chain.
Issues related to data privacy. Issues related to artificial intelligence.
Filing targets: Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to the U.S. financial services transaction and payments processing industry, including cybersecurity.
Issues related to FY26 appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to promoting the use of geosynthetic materials in civil infrastructure, including aviation infrastructure. Issues related to the implementation of H.R. 3684, the the Infrastructure Investment and Jobs Act (IIJA). Issues related to Buy America. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022. Issues related to surface transportation reauthorization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
Issues related to higher education and community colleges and workforce training initiatives. Issues related to apprenticeship programs. Issues related to the nursing shortage.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE
Issues related to artificial intelligence as a service and contracting opportunities.
Issues related to prescription drug pricing. Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. Ensuring Timely Access to Generics Act. S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to offshore wind and oil / gas platforms and offshore energy infrastructure construction.
Issues related to H. R. 8070, the Servicemember Quality of Life Improvement Act and National Defense Authorization Act for Fiscal Year 2025.
Issues related to S. 2572 and H.R. 4016, the Department of Defense Appropriations Act, 2026. Issues related to H.R.5342 and S. 2354, the Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026. Issues related to H.R. 4552 and S. 2465, the Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026. Issues related to H.R. 4213, the Department of Homeland Security Appropriations Act, 2026.
Issues related to homeland security, transportation, and innovative marine vessel design and capabilities. Issues related to ice breaking technologies.
Filing targets: Federal Transit Administration (FTA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to innovative products and services to enhance environmental sustainability. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022. Issues related to critical minerals including domestic sourcing and supply chain.
Issues related to data privacy. Issues related to artificial intelligence.
Filing targets: Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to the U.S. financial services transaction and payments processing industry, including cybersecurity.
Issues related to FY26 appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the implementation of H.R. 3684, the Infrastructure Investment and Jobs Act (IIJA). Issues related to Buy America. Issues related to energy and environmental permitting reform. Issues related to permitting reform in H.R. 1, the Lower Energy Costs Act. Issues related to the implementation of H.R. 5376, the Inflation Reduction Act of 2022.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
Issues related to veterans benefit programs and education opportunities.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE